{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/DNTH/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T04:44:44.183Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6789,"canonical_name":"Dianthus Therapeutics, Inc. /DE/","cik":"0001690585","uei":null,"lei":null,"duns":null,"ticker":"DNTH"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":46},"count":46,"timeline":[{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — Dianthus Therapeutics, Inc. /DE/ — 2026-08-11","url_slug":"/sec/cik-0001690585/4/0001778623-26-000007","accession_number":"0001778623-26-000007","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — Dianthus Therapeutics, Inc. /DE/ — 2026-08-11","url_slug":"/sec/cik-0001690585/4/0001779934-26-000004","accession_number":"0001779934-26-000004","importance":30},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":16167,"price_per_share":110.38,"usd_value":1784513,"security_title":"Common Stock","importance":36.78451346},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"McGeorge Anne","title":null,"shares":2800,"price_per_share":108.38,"usd_value":303464,"security_title":"Common Stock","importance":35.303464},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"McGeorge Anne","title":null,"shares":1800,"price_per_share":109.3,"usd_value":196740,"security_title":"Common Stock","importance":35.19674},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"McGeorge Anne","title":null,"shares":1450,"price_per_share":107.58,"usd_value":155991,"security_title":"Common Stock","importance":35.155991},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"McGeorge Anne","title":null,"shares":1000,"price_per_share":110.64,"usd_value":110640,"security_title":"Common Stock","importance":35.11064},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":831,"price_per_share":108.95,"usd_value":90537,"security_title":"Common Stock","importance":35.09053745},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":737,"price_per_share":108.17,"usd_value":79721,"security_title":"Common Stock","importance":35.07972129},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"McGeorge Anne","title":null,"shares":700,"price_per_share":111.41,"usd_value":77987,"security_title":"Common Stock","importance":35.077987},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":470,"price_per_share":111.05,"usd_value":52194,"security_title":"Common Stock","importance":35.0521935},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":397,"price_per_share":111.77,"usd_value":44373,"security_title":"Common Stock","importance":35.04437269},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":272,"price_per_share":109.96,"usd_value":29909,"security_title":"Common Stock","importance":35.02990912},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Read Simon","title":null,"shares":70,"price_per_share":107.11,"usd_value":7498,"security_title":"Common Stock","importance":35.0074977},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":16167,"price_per_share":17.88,"usd_value":289066,"security_title":"Common Stock","importance":15.28906596},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"McGeorge Anne","title":null,"shares":6500,"price_per_share":11.2,"usd_value":72800,"security_title":"Common Stock","importance":15.0728},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Read Simon","title":null,"shares":2777,"price_per_share":18.36,"usd_value":50986,"security_title":"Common Stock","importance":15.05098572},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"McGeorge Anne","title":null,"shares":1250,"price_per_share":19.36,"usd_value":24200,"security_title":"Common Stock","importance":15.0242},{"ts":"2026-08-07","kind":"sec.insider.s","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":3217,"price_per_share":110.61,"usd_value":355832,"security_title":"Common Stock","importance":35.35583237},{"ts":"2026-08-07","kind":"sec.insider.s","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":616,"price_per_share":111.18,"usd_value":68487,"security_title":"Common Stock","importance":35.06848688},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":3833,"price_per_share":17.88,"usd_value":68534,"security_title":"Common Stock","importance":15.06853404},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Dianthus Therapeutics, Inc. /DE/ — 2026-07-13","url_slug":"/sec/cik-0001690585/4/0001992324-26-000008","accession_number":"0001992324-26-000008","importance":30},{"ts":"2026-07-09","kind":"sec.form144","reporter":"RYAN SAVITZ","title":"Officer","shares":31249,"usd_value":3064589,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001950047-26-006986","importance":40.612917886},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Savitz Ryan","title":"EVP, CFO & CBO","shares":15329,"price_per_share":101.24,"usd_value":1551908,"security_title":"Common Stock","importance":36.55190796},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Savitz Ryan","title":"EVP, CFO & CBO","shares":10354,"price_per_share":100.22,"usd_value":1037678,"security_title":"Common Stock","importance":36.03767788},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Savitz Ryan","title":"EVP, CFO & CBO","shares":5566,"price_per_share":101.97,"usd_value":567565,"security_title":"Common Stock","importance":35.56756502},{"ts":"2026-07-09","kind":"sec.filing","form_type":"144","title":"144 — Dianthus Therapeutics, Inc. /DE/ — 2026-07-09","url_slug":"/sec/cik-0001690585/144/0001950047-26-006986","accession_number":"0001950047-26-006986","importance":30},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Savitz Ryan","title":"EVP, CFO & CBO","shares":31249,"price_per_share":21.77,"usd_value":680291,"security_title":"Common Stock","importance":15.68029073},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Dianthus Therapeutics, Inc. /DE/ — 2026-06-18","url_slug":"/sec/cik-0001690585/4/0001778623-26-000005","accession_number":"0001778623-26-000005","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"ADAM M VENESS","title":"Officer","shares":30000,"usd_value":2366400,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006275","importance":40.47328},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":16771,"price_per_share":80.34,"usd_value":1347382,"security_title":"Common Stock","importance":36.34738214},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":13229,"price_per_share":81.38,"usd_value":1076576,"security_title":"Common Stock","importance":36.07657602},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Veness Adam M","title":"SVP, General Counsel and Sec.","shares":30000,"price_per_share":17.88,"usd_value":536400,"security_title":"Common Stock","importance":15.5364},{"ts":"2026-06-01","kind":"sec.form144","reporter":"SIMRAT RANDHAWA","title":"Officer","shares":26530,"usd_value":2467555,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005356","importance":40.49351106},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":16943,"price_per_share":90.72,"usd_value":1537069,"security_title":"Common Stock","importance":36.53706896},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":5428,"price_per_share":89.72,"usd_value":487000,"security_title":"Common Stock","importance":35.48700016},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":4159,"price_per_share":91.37,"usd_value":380008,"security_title":"Common Stock","importance":35.38000783},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Dianthus Therapeutics, Inc. /DE/ — 2026-06-01","url_slug":"/sec/cik-0001690585/144/0001950047-26-005356","accession_number":"0001950047-26-005356","importance":30},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":9375,"price_per_share":22.07,"usd_value":206906,"security_title":"Common Stock","importance":15.20690625},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":6249,"price_per_share":21.77,"usd_value":136041,"security_title":"Common Stock","importance":15.13604073},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":6908,"price_per_share":17.88,"usd_value":123515,"security_title":"Common Stock","importance":15.12351504},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Randhawa Simrat","title":"EVP, Head of R&D","shares":3998,"price_per_share":8.44,"usd_value":33743,"security_title":"Common Stock","importance":15.03374312},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Dianthus Therapeutics, Inc. /DE/ — 2026-05-15","url_slug":"/sec/cik-0001690585/schedule-13g/0000919574-26-003219","accession_number":"0000919574-26-003219","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Dianthus Therapeutics, Inc. /DE/ — 2026-05-15","url_slug":"/sec/cik-0001690585/schedule-13g-a/0000902219-26-000166","accession_number":"0000902219-26-000166","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Dianthus Therapeutics, Inc. /DE/ — 2026-05-14","url_slug":"/sec/cik-0001690585/schedule-13g-a/0001214659-26-006203","accession_number":"0001214659-26-006203","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Dianthus Therapeutics, Inc. /DE/ — 2026-04-27","url_slug":"/sec/cik-0001690585/schedule-13g/0002012383-26-001740","accession_number":"0002012383-26-001740","importance":55}]}